Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019

NEXT STORY
Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
PREV STORY
Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting

Company Announcement Oral plenary session presentation on daratumumab Phase III Castor study data Trial ...

author_avatar
NASDAQ Market News

VBL Therapeutics Announces New Milestone Event in the VB-201 Collaboration for Veterinary Use

author_avatar
NASDAQ Market News

Oncology Venture: Notice to Convene Extraordinary General Meeting

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes ...

author_avatar
NASDAQ Market News